Cardiac Sutures Global Market Report 2024

The cardiac sutures market has grown strongly in recent years. It will grow from $1.39 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth observed in the previous period can be attributed to several key factors. These include the evolution and advancement of surgical procedures, a notable increase in cardiovascular diseases, a surge in minimally invasive surgical techniques, the growing population of older adults, and significant investments in research and development within the medical field. These factors collectively contributed to the growth witnessed during that timeframe in the realm of cardiac sutures and associated surgical interventions.

The cardiac sutures market is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. Anticipated growth in the upcoming period is expected to stem from several influential factors. These encompass the ongoing expansion of global healthcare infrastructure, a heightened focus on improving patient outcomes and post-operative recovery, the evolving preferences and specialization among surgeons, the adherence to regulatory compliance and stringent standards within the medical field, and an increasing demand for biodegradable sutures owing to environmental considerations.

The escalating prevalence of cardiovascular diseases is anticipated to be the driving force behind the expansion of the cardiac suture market. These diseases encompass various heart and blood vessel conditions. Cardiac sutures play a critical role in wound closure and providing mechanical support post-cardiovascular surgeries. For instance, data published by the Centers for Disease Control and Prevention in October 2022 revealed that approximately 20.1 million individuals aged 20 and older suffer from cardiovascular diseases in the United States. Additionally, cardiovascular disease (CVD) remains the leading cause of mortality in the US, accounting for 695,000 deaths in 2021. Consequently, the increasing prevalence of cardiovascular diseases is poised to propel the cardiac sutures market.

The expanding geriatric population is expected to significantly contribute to the growth of the cardiac sutures market. The geriatric demographic, comprising individuals aged 65 and above, presents distinct challenges in cardiac suture requirements due to age-related tissue changes. This population group tends to have reduced post-operative healing capabilities, necessitating sutures that facilitate faster tissue repair and minimize scarring. According to the World Health Organization's report in October 2023, the global population aged 60 or older is projected to reach 1.4 billion by 2030 and 2.1 billion by 2050. Hence, the burgeoning geriatric population is a key driver of growth in the cardiac sutures market.

Product innovation stands out as a pivotal trend in the cardiac suture market, with major companies striving for new advancements to bolster their market standing. For instance, Able Medical Devices, a US-based medical equipment manufacturer, introduced its Valkyrie looped sternotomy sutures in January 2023, specifically tailored for post-open heart surgeries. This innovative product utilizes stainless steel sutures for closing a patient's chest post-open heart surgery. The Valkyrie sutures offer a doubled surface area compared to traditional wire sutures, ensuring a more robust sternal closure to reduce the risk of severe complications such as sternal dehiscence, often seen after sternotomy procedures. Its unique features include a looped design, high tensile strength, minimal invasiveness, and ease of use, ultimately improving patient outcomes.

Major companies in the cardiac suture market are focusing on technological innovations, such as robotic platform technology, to gain a competitive edge. Origami Surgical Inc., a US-based provider of robotic-assisted surgery solutions, obtained FDA clearance for its StitchKit robotic platform in March 2021. This platform enhances robotic-assisted surgery by streamlining the suturing process, improving efficiency, and boosting safety in the operating room. StitchKit, a patented technology platform, allows robotic surgeons to manage suture use and needle disposal independently, eliminating the need for an assistant. It employs a disposable cartridge pre-loaded with sutures and needles, along with a secure container for used needles, optimizing the suturing process during surgery.

In April 2023, Boston Scientific Corporation, a US-based biotechnology engineering firm, acquired Apollo Endosurgery Inc. to fortify its position in the minimally invasive surgery market and expand its global market share. Apollo Endosurgery Inc., specializing in devices such as sutures and suturing devices, contributed significantly to advancing therapeutic endoscopy.

Major companies operating in the cardiac sutures market report are Abbott Laboratories, Medtronic plc, Johnson & Johnson, B. Braun SE, Teleflex Incorporated, Smith & Nephew plc, Boston Scientific Corporation, CONMED Corporation, Deme TECH Corporation, Apollo Endosurgery Inc., Cryolife Inc., W. L. Gore & Associates Inc., Peters Surgical, Stryker Corporation, Ethicon Inc., Internacional Farmacéutica, Sutures India, Mellon Medical B.V., EndoEvolution LLC, Surgical Specialties Corporation, Arthrex Inc., Covidien Holding Inc., Gunze Ltd., Centennial Surgical Suture Ltd., Assut Medical Sarl, Healthium Medtech Ltd., Meril Life Sciences Pvt. Ltd., Cardiovascular Systems Inc., Gore Medical Inc., LivaNova plc.

North America was the largest region in the cardiac sutures market in 2023. The regions covered in the cardiac sutures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac sutures market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary classifications of cardiac sutures include absorbable and non-absorbable types. Absorbable sutures naturally break down and are assimilated by the body as the wound undergoes healing. These sutures encompass a range of natural and synthetic materials, finding application across diverse end-users, including hospitals, clinics, ambulatory surgical centers, and various medical facilities.

The cardiac sutures market research report provides cardiac sutures market statistics, including cardiac sutures industry global market size, regional shares, competitors with a cardiac sutures market share, detailed cardiac sutures market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiac sutures industry. The cardiac sutures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac sutures market consists of sales of stainless steel, polypropylene, and polyester sutures and suture anchors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.